Sustained Glipizide Release and Enhanced Hypoglycemia With Nano‐Mesoporous SBA‐15 in Diabetic Mice
Journal of Biochemical and Molecular Toxicology · 2026
DOI: 10.1002/jbt.70759 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Moath Alqaraleh und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al‑Balqa Applied University, Al‑Salt, Jordan. Hauptthemen laut MEDLINE: Glipizide, Silicon Dioxide, Diabetes Mellitus, Experimental, Hypoglycemia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Gefördert von: University of Jordan.
Abstract (Originalsprache)
Glipizide is an oral hypoglycemic medication that has many limitations in its therapeutic use due to poor aqueous solubility and low plasma half‐life. These disadvantages result in inefficient glycemic regulation and a high frequency of dosing. To develop and test different mesoporous silica nanocarriers (MSN), especially Santa Barbara Amorphous‐15 (SBA‐15), to deliver glipizide continuously and enhance the overall therapeutic effects on diabetic mice. Nano‐mesoporous carriers (Mobil Composition of Matter No. 41 [MCM‐41], SBA‐15, and Hollow Mesoporous Nanoparticles [HMNs]) were synthesized and loaded with glipizide. After assessing drug encapsulation efficiency, SBA‐15 was selected as the model for our study. SBA‐15 and SBA‐15 with surface‐modified amine groups were characterized using zeta potential, Fourier‐transform infrared spectroscopy (FTIR), scanning microscopy (SEM), and X‐ray diffraction (XRD). In vivo evaluation of SBA‐15 loaded with glipizide was conducted using streptozotocin‐induced diabetic mice to measure glucose and insulin levels. Glipizide entrapment was highest in SBA‐15 compared to other nano‐mesoporous carriers. The high surface area, large pore diameter, and uniform morphology were confirmed by characterization, which facilitates efficient loading of drugs and stable amorphous dispersion of glipizide. In vitro dissolution revealed that there was a high pH dependence: at gastric pH (1.0), SBA‐15/glipizide released approximately 25% at 2 h, and with further release thereafter, whilst at intestinal pH (7.4) it released approximately 90% at 2 h, and sustained release thereafter. Furthermore, the study on streptozotocin‐induced diabetic mice showed that SBA‐15 loaded with glipizide significantly reduced glucose levels and enhanced insulin release over 48 h compared to glipizide alone. SBA‐15 is a viable nanocarrier of glipizide that offers high encapsulation efficiency, good physicochemical characteristics, and long‐term pH‐dependent release, resulting in long‐term therapy. This intervention has the potential to improve diabetes management and patient adherence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Sciences, Faculty of Allied Medical Sciences, Al‑Balqa Applied University, Al‑Salt, Jordan.
- Pharmacological and Diagnostic Research Center (PDRC), Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, Jordan.
- Faculty of Pharmacy, The RAK Medical & Health Sciences, Ras Al Khimah, UAE.
- Department of Chemistry, School of Science, The University of Jordan, Amman, Jordan.
- Department of Biological Sciences, Faculty of Science, Mutah University, Al-Karak, Jordan.
- Zarqa University College, Al-Balqa Applied University, Zarqa, Jordan.
ORCID-Profile: Moath Alqaraleh, Bassam El-Eswed
Förderung
- University of Jordan
Zitieren
APA
Alqaraleh, M., Muhana, F., Shakya, A., El-Tanani, M., Khalili, F., Al-Sanabrah, A., Alkhrissat, T., Malhis, A., Kadhim, A., Al Qaisi, Y. T., Alsarayreh, A. Z., Khleifat, K., Mousa, M. A., & El-Eswed, B. (2026). Sustained Glipizide Release and Enhanced Hypoglycemia With Nano‐Mesoporous SBA‐15 in Diabetic Mice. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70759
Vancouver
Alqaraleh M, Muhana F, Shakya A, El-Tanani M, Khalili F, Al-Sanabrah A, et al. Sustained Glipizide Release and Enhanced Hypoglycemia With Nano‐Mesoporous SBA‐15 in Diabetic Mice. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.70759
BibTeX
@article{Alqaraleh2026,
author = {Alqaraleh, Moath and Muhana, Frezah and Shakya, Ashok and El-Tanani, Mohamed and Khalili, Fawwaz and Al-Sanabrah, Alaa and Alkhrissat, Tariq and Malhis, Abeer and Kadhim, Akram and Al Qaisi, Yaseen T and Alsarayreh, Ahmad Z and Khleifat, Khaled and Mousa, Mohamad Ak and El-Eswed, Bassam},
title = {Sustained Glipizide Release and Enhanced Hypoglycemia With Nano‐Mesoporous SBA‐15 in Diabetic Mice},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
doi = {10.1002/jbt.70759}
}
EUVIMED